FDA Inspection 1278335 — Dee Cee Laboratories, Inc

Dee Cee Laboratories, Inc — FEI 1023013

The FDA completed an inspection of Dee Cee Laboratories, Inc on August 11, 2025 in White House, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
White House, TN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
192821 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
195721 CFR 211.180(e)(2)Review of problem drugs
358321 CFR 211.110(a)Written in-process control procedures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
430321 CFR 211.67(b)Written procedures fail to include